EUVIMEDEUVIMED entdecken
Crossref

Dual delivery of carbon monoxide and doxorubicin using haemoglobin–albumin cluster: proof of concept for well-tolerated cancer therapy

Chihiro Ito, Kazuaki Taguchi iD, Taiga Yamada iD, Kengo Hanaya iD, Yuki Enoki, Takeshi Sugai iD, Teruyuki Komatsu iD, Kazuaki Matsumoto iD

Journal of Materials Chemistry B · 2024

DOI: 10.1039/d4tb00123k ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2024. Verfasst von Chihiro Ito und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacodynamics, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan. taguchi-kz@keio.jp. Hauptthemen laut MEDLINE: Doxorubicin, Carbon Monoxide, Hemoglobins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Japan Science and Technology Agency, Mochida Memorial Foundation for Medical and Pharmaceutical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The dual delivery of CO and DOX using HemoAct is a promising strategy as an anti-tumour agent to realise well-tolerated cancer therapy with minimal cardiotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinCarbon MonoxideHemoglobinsAnimalsMiceHumansDrug CarriersMice, Inbred BALB CAntibiotics, AntineoplasticAntineoplastic AgentsCell Line, TumorCell ProliferationDrug Screening Assays, AntitumorDrug Delivery SystemsNeoplasms, ExperimentalCell Survival

Substanzen

DoxorubicinCarbon MonoxideHemoglobinsDrug CarriersAntibiotics, AntineoplasticAntineoplastic Agents

Autor:innen und Institutionen

  • Division of Pharmacodynamics, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan. taguchi-kz@keio.jp.
  • Department of Applied Chemistry, Faculty of Science and Engineering, Chuo University, 1-13-27 Kasuga, Bunkyo-ku, Tokyo 112-8551, Japan.
  • Division of Organic and Biocatalytic Chemistry, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan.

ORCID-Profile: Kazuaki Taguchi, Taiga Yamada, Kengo Hanaya, Takeshi Sugai, Teruyuki Komatsu, Kazuaki Matsumoto

Förderung

  • Japan Science and Technology Agency
  • Mochida Memorial Foundation for Medical and Pharmaceutical Research

Zitieren

APA

Ito, C., Taguchi, K., Yamada, T., Hanaya, K., Enoki, Y., Sugai, T., Komatsu, T., & Matsumoto, K. (2024). Dual delivery of carbon monoxide and doxorubicin using haemoglobin–albumin cluster: proof of concept for well-tolerated cancer therapy. Journal of Materials Chemistry B. https://doi.org/10.1039/d4tb00123k

Vancouver

Ito C, Taguchi K, Yamada T, Hanaya K, Enoki Y, Sugai T, et al. Dual delivery of carbon monoxide and doxorubicin using haemoglobin–albumin cluster: proof of concept for well-tolerated cancer therapy. Journal of Materials Chemistry B. 2024. doi:10.1039/d4tb00123k

BibTeX
@article{Ito2024,
  author = {Ito, Chihiro and Taguchi, Kazuaki and Yamada, Taiga and Hanaya, Kengo and Enoki, Yuki and Sugai, Takeshi and Komatsu, Teruyuki and Matsumoto, Kazuaki},
  title = {Dual delivery of carbon monoxide and doxorubicin using haemoglobin–albumin cluster: proof of concept for well-tolerated cancer therapy},
  journal = {Journal of Materials Chemistry B},
  year = {2024},
  doi = {10.1039/d4tb00123k}
}
Kostenlos starten →